Pharmacytimes: Condition Center: Hepatitis C Hepatitis C en-us Mon, 24 Oct 2016 11:45:03 UTC Mon, 24 Oct 2016 11:45:03 UTC FDA Approves Hep C Treatment for All Major Genotypes The FDA today approved Gilead Sciences’ sofosbuvir and velpatasvir (Epclusa) for the treatment of adult patients with chronic hepatitis C virus both with and without cirrhosis. Tue, 28 Jun 2016 08:25:00 UTC HIV Coinfection Doesn't Affect Hep C Treatment Adherence One-third of HIV-infected Americans are co-infected with hepatitis C virus (HCV), and 75% to 90% of HIV-positive intravenous drug users are co-infected. Thu, 21 Jan 2016 04:59:00 UTC Newly Infected HIV Patients Have Low Prevalence of Hep C Co-Infection The World Health Organization indicates that 35 million individuals have HIV worldwide, and 4 to 5 million HIV-infected patients are co-infected with hepatitis C virus. Fri, 04 Dec 2015 03:00:00 UTC New Drugs Health-System Pharmacists Should Know Here are new drugs for 2015 pharmacists can expect to handle. Thu, 18 Jun 2015 04:26:00 UTC Can Certain Antiretroviral Therapies Cause Cirrhosis? Liver damage is the bane of HIV-infected patients' existence. Mon, 11 May 2015 01:00:00 UTC Costly Hepatitis C Drugs Pose Pharmacy Budget Problems for Prisons Treating prisoners for hepatitis C virus can be a costly nightmare, straining prisons' pharmacy and health care budgets. Sun, 12 Apr 2015 05:00:00 UTC New Hepatitis C Regimens Have Adherence Issues Advances in treatment for chronic hepatitis C virus have been breaking news in the last few years. Wed, 01 Apr 2015 03:00:00 UTC Interferon-Free Drugs Effective for Hepatitis C, HIV Co-Infection Interferon-free, all-oral drug regimens result in high rates of sustained virologic response for patients co-infected with hepatitis C virus and HIV. Tue, 03 Mar 2015 05:51:00 UTC Researchers Identify How Hepatitis Leads to Liver Cancer A recent study has identified how chronic hepatitis infection can pave the way to liver cancer. Fri, 06 Feb 2015 04:18:00 UTC How Hepatitis C Therapies are Changing Patient Treatment Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment. Sat, 10 Jan 2015 02:18:00 UTC More Awareness of Hepatitis C Patients Needed A new study has revealed that many patients infected with the hepatitis C virus do not seek treatment and become lost in the different stages of health care to manage the disease. Wed, 24 Dec 2014 01:32:55 UTC Researchers Set to Study Hepatitis C Therapy in Children Researchers from Saint Louis University Medical Center will test the safety and efficacy of sofosbuvir and ribavirin in children with hepatitis C. Sat, 04 Oct 2014 01:40:59 UTC Polypharmacy Hinders HIV Drug Adherence Among HIV-positive patients, concurrent use of medications is associated with nonadherence to antiretroviral therapy. Sat, 27 Sep 2014 04:33:01 UTC Combination Treatment for HIV/HCV Coinfection Shown Effective in Phase 3 Trial Results of a phase 3 trial demonstrate the effectiveness of simeprevir in combination with ribavirin and peginterferon as a treatment for patients coinfected with HIV and HCV. Tue, 16 Sep 2014 02:56:43 UTC Hepatitis C Patients with HIV Co-Infection Vulnerable to Serious Liver Disease Despite Antiretroviral Therapy A study finds that patients co-infected with hepatitis C and HIV who are receiving antiretroviral therapy are 80% more likely to have serious liver disease than those with hepatitis C alone. Fri, 23 May 2014 01:00:54 UTC Community Pharmacies Well-Situated to Offer Point-of-Care Infectious Disease Testing By offering quick and convenient tests for diseases such as influenza, HIV, and hepatitis C, community pharmacies could help improve prevention and treatment. Mon, 14 Apr 2014 08:18:55 UTC Multiple Tactics Needed to Combat Hepatitis C in Young Drug Users With hepatitis C infections on the rise among young injection drug users, researchers have recommended a range of promising prevention tactics. Wed, 07 Aug 2013 04:16:31 UTC Task Force Recommends Hepatitis C Testing for Baby Boomers The U.S. Preventive Services Task Force recommends that all patients born between 1945 and 1965 as well as high-risk patients of all ages be tested for hepatitis C. Tue, 09 Jul 2013 07:57:10 UTC CDC Urges All Baby Boomers to Get Tested for Hepatitis C Testing baby boomers could help identify more than 800,000 new cases of hepatitis C and address the largely preventable consequences of the condition. Fri, 08 Jun 2012 04:46:49 UTC Triple Therapy for Hepatitis C Can Be Cost-Effective New triple-therapy regimens for hepatitis C are expensive, but they can be cost-effective for many patients. Mon, 27 Feb 2012 05:20:09 UTC